Acre Pharmacy Makes £2m Deal with Texoane


Alongside Geneva based Texoane, Acre Pharmacy has agreed to a transaction with an expected value of £2 million over the coming year.

Teoxane has specific expertise within wrinkle-reducing skincare and injectable dermal fillers with a high concentration of hyaluronic acid.

“Acre Pharmacy has agreed to a transaction with an expected value of £2 million“

22 people currently work at Acre, which is a subsidiary of CST Holdings Group.

The online direct patient care provider, Acre, will join the aesthetics medicine and skincare company as a verified UK partner.

Acre’s Director, Neil Clarkson, explained that “this deal is the first of many in the coming months that secure our place as one of the UK’s leading online pharmacies.”

“Our continued success and growth are down to the dedication, hard work and proficiencies of our expert team. I look forward to announcing more positive news as we encroach on 2023.”

“Teoxane has a strong presence in the aesthetics and skincare industry rooted in research and development.” This “reinforces patient safety and customer satisfaction along with product reliability.”

Acre Pharmacy is set "on a mission to create a global footprint within the aesthetics medicine and skincare industry where innovation and excellence are integral, and we are now proud to be part of that journey.”

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.

See all the latest jobs in Consumer
Return to news